AXQ Capital LP acquired a new stake in shares of Amdocs Limited (NASDAQ:DOX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 8,555 shares of the technology company's stock, valued at approximately $728,000.
Several other large investors have also recently added to or reduced their stakes in DOX. Summit Global Investments purchased a new stake in shares of Amdocs during the 4th quarter worth about $1,813,000. Northwest & Ethical Investments L.P. raised its position in Amdocs by 8.0% during the fourth quarter. Northwest & Ethical Investments L.P. now owns 190,050 shares of the technology company's stock valued at $16,181,000 after acquiring an additional 14,015 shares in the last quarter. Lingohr Asset Management GmbH lifted its stake in Amdocs by 42.1% in the fourth quarter. Lingohr Asset Management GmbH now owns 11,064 shares of the technology company's stock valued at $938,000 after acquiring an additional 3,277 shares during the last quarter. Xponance Inc. grew its position in Amdocs by 15.5% in the fourth quarter. Xponance Inc. now owns 5,039 shares of the technology company's stock worth $429,000 after acquiring an additional 675 shares in the last quarter. Finally, Haven Capital Group Inc. acquired a new position in shares of Amdocs during the 4th quarter worth $200,000. Institutional investors and hedge funds own 92.02% of the company's stock.
Amdocs Stock Performance
NASDAQ:DOX traded up $0.05 during midday trading on Thursday, reaching $92.02. The stock had a trading volume of 504,135 shares, compared to its average volume of 656,896. The stock has a market capitalization of $10.39 billion, a P/E ratio of 21.35, a PEG ratio of 1.47 and a beta of 0.68. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $93.34. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.16 and a quick ratio of 1.20. The firm's fifty day simple moving average is $87.62 and its 200-day simple moving average is $87.26.
Amdocs (NASDAQ:DOX - Get Free Report) last announced its earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a net margin of 10.19% and a return on equity of 18.89%. On average, equities research analysts forecast that Amdocs Limited will post 6.21 EPS for the current fiscal year.
Amdocs Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Monday, March 31st will be paid a $0.527 dividend. This represents a $2.11 annualized dividend and a dividend yield of 2.29%. The ex-dividend date is Monday, March 31st. This is a boost from Amdocs's previous quarterly dividend of $0.48. Amdocs's dividend payout ratio (DPR) is presently 48.72%.
Analysts Set New Price Targets
Separately, StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat, Amdocs presently has a consensus rating of "Moderate Buy" and an average target price of $101.20.
Get Our Latest Research Report on Amdocs
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles

Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.